Treatment of ophthalmic conditions with mineralcorticoids

Details for Australian Patent Application No. 2005232693 (hide)

Owner Eye Co Pty Ltd

Inventors Sanders, Donald Robert; Peyman, Gholam Ali; Penfold, Philip Leslie

Agent Wrays

Pub. Number AU-B-2005232693

PCT Pub. Number WO2005/099715

Priority 2004905034 03.09.04 AU; 2004901916 08.04.04 AU; 2004905035 03.09.04 AU

Filing date 8 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 12 January 2012

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/099715 Priority application(s): WO2005/099715

7 December 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Nov 2006

21 December 2006 Assignment before Grant

  RetMed Pty Ltd; Sanders, Donald; Peyman, Gholam The application has been assigned to Advanced Ocular Systems Limited

15 December 2011 Assignment before Grant

  Advanced Ocular Systems Limited The application has been assigned to Eye Co Pty Ltd

12 January 2012 Application Accepted

  Published as AU-B-2005232693

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232696-Method and system of providing sealed bags of fluid at the clean side of laboratory facility

2005232685-Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use